Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.61 USD | -0.43% | -3.36% | -29.77% |
May. 13 | Transcript : Zevra Therapeutics, Inc. - Shareholder/Analyst Call | |
May. 08 | Earnings Flash (ZVRA) ZEVRA THERAPEUTICS Reports Q1 Revenue $3.4M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.77% | 194M | |
+9.28% | 8.74B | |
-14.24% | 4.94B | |
+49.95% | 4.7B | |
+5.96% | 3.98B | |
-23.57% | 2.28B | |
+13.33% | 2.28B | |
+17.77% | 2.14B | |
-32.28% | 2.12B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- ZVRA Stock
- News Zevra Therapeutics, Inc.
- Zevra Therapeutics Says Interim Data Show KP1077 for Idiopathic Hypersomnia Well-Tolerated at All Dose Levels